These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 406584)

  • 1. [Thio-Tepa in the chemotherapy and chemical prevention of papillary neoplasms of the bladder].
    Delzotto L; Viggiano G; Marchini M; Barbui PE
    Minerva Med; 1977 Jun; 68(28):1957-60. PubMed ID: 406584
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intravascular thio-tepa in the treatment of papillary neoplasms of the bladder].
    Furnari S; Lattuca C; Pavone-Macaluso M; Leone G
    Arch Ital Urol Nefrol; 1968; 41(3):187-98. PubMed ID: 4982415
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thio-tepa in the prevention of recurrences of papillary bladder tumors].
    Kierfeld G; Mellin P
    Z Urol Nephrol; 1973 Aug; 66(8):569-72. PubMed ID: 4204011
    [No Abstract]   [Full Text] [Related]  

  • 4. [Personal experience with thio-tepa in the treatment of papillomas and superficial carcinomas of the bladder].
    Pellet A; Djulepa J
    Ther Umsch; 1970 May; 27(5):310-3. PubMed ID: 4994886
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy in superficial neoplasms of the bladder.
    Zingg E; Sulmoni A
    S Afr Med J; 1972 Jul; 46(27):916-7. PubMed ID: 4626807
    [No Abstract]   [Full Text] [Related]  

  • 6. Local application of THIO-TEPA in the prevention of recurrent papillary carcinoma of the bladder.
    Csellár M; Csontai A
    Int Urol Nephrol; 1979; 11(1):39-44. PubMed ID: 112079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical use of Thio-Tepa for tumours of the bladder.
    Oravisto KJ
    Urol Int; 1965; 20(1):23-8. PubMed ID: 4953655
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
    Mukamel E; Zitron S; Nissenkorn I; Servadio C
    Isr J Med Sci; 1980; 16(9-10):714-6. PubMed ID: 6776072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thio-tepa treatment for prevention of recurrence of surgically treated bladder tumors].
    Neagoe M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1980; 29(4):259-65. PubMed ID: 6457322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intraluminal visceral chemotherapy of noninfiltrating cancers of the bladder (preliminary report)].
    Mocellini Iturralde JA; Rapaport M; Montenegro L; Arrighi A
    Rev Argent Urol Nefrol; 1970; 39(7):144-51. PubMed ID: 4999227
    [No Abstract]   [Full Text] [Related]  

  • 11. EORTC randomized trial for the adjuvant therapy of T1 bladder carcinoma.
    Schulman CC; Rozencweig M; Staquet M; Kenis Y; Sylvester R
    Eur Urol; 1976; 2(6):271-3. PubMed ID: 829223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of superficial bladder cancer.
    Soloway MS
    Cancer; 1980 Apr; 45(7 Suppl):1856-65. PubMed ID: 6768441
    [No Abstract]   [Full Text] [Related]  

  • 13. [Our previous experiences with thio-TEPA in therapy and prevention of bladder papilloma].
    Zingg E; Rutishauser G
    Helv Chir Acta; 1967 Aug; 34(4):353-8. PubMed ID: 4969477
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy for bladder cancer.
    Veenema RJ; Romas NA; Fingerhut B
    Urology; 1974 Feb; 3(2):135-9. PubMed ID: 4204755
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myelodepressive effect during intracavitary cytostatic treatment of bladder tumors].
    González R; Millones A; Guzmán A; Gelabert A
    Arch Esp Urol; 1979; 32(1):49-52. PubMed ID: 109052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serious complications following topical administration of thio-tepa in a patient with bladder carcinoma].
    Kaczmarek A
    Wiad Lek; 1978 Apr; 31(8):547-50. PubMed ID: 96607
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intravesical application of thio-tepa for preventing postoperative recurrence of bladder carcinoma].
    Zhang SX; Deng XZ; Tang XD
    Zhonghua Wai Ke Za Zhi; 1986 Aug; 24(8):486-7, 510. PubMed ID: 3102180
    [No Abstract]   [Full Text] [Related]  

  • 18. The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.
    Dobrzecki W; Kaczmarek A
    Int Urol Nephrol; 1977; 9(2):145-9. PubMed ID: 412808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Own experiences with the treatment of papillomatous bladder neoplasms by intracystic administration of Thio-Tepa].
    Dobrzecki W; Kaczmarek A
    Pol Przegl Chir; 1977 Jun; 49(6a):743-8. PubMed ID: 407554
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of chemotherapeutic agents in the prophylaxis of papillary bladder tumours.
    Pavone-Macaluso M; Caramia G; Rizzo FP
    Urol Int; 1971; 26(5):379-87. PubMed ID: 5136749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.